New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
10:00 EDTFUEL, TTGT, PTCT, SONS, NAO, MOBL, EBMT, MDCA, CLGX, GLNG, CHEFOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Chef's Warehouse (CHEF) initiated with a Market Perform at BMO Capital... CoreLogic (CLGX) initiated with a Buy at Monness Crespi... Eagle Bancorp (EBMT) initiated with an Outperform at Fig Partners... Golar LNG (GLNG) initiated with a Buy at BofA/Merrill... MDC Partners (MDCA) initiated with an Overweight at Evercore... MobileIron (MOBL) initiated with a Buy at Deutsche Bank... Nordic American Offshore (NAO) initiated with an Overweight at Morgan Stanley... PTC Therapeutics (PTCT) initiated with a Buy at Roth Capital... Rocket Fuel (FUEL) initiated with a Market Perform at Wells Fargo... Sonus Networks (SONS) initiated with an Outperform at Pacific Crest... TechTarget (TTGT) initiated with a Buy at Craig-Hallum.
News For CHEF;CLGX;EBMT;GLNG;MDCA;MOBL;NAO;PTCT;FUEL;SONS;TTGT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 24, 2015
10:08 EDTFUELOptions with decreasing implied volatility
Subscribe for More Information
08:36 EDTMDCAMDC Partners should be bought on any weakness, says FBR Capital
Subscribe for More Information
February 23, 2015
16:27 EDTPTCTOn The Fly: Closing Wrap
Stocks on Wall Street began the session in negative territory and remained there for most of the session, with the Nasdaq the lone index to post a small gain. The Dow was weighed down by shares of Boeing (BA), which slid after the stock received a downgrade. There was little in the way of positive economic news, as the most notable report showed existing homes were lower than expected due to a shortage of inventory. The averages drifted for most of the session, as investors may be waiting on the sidelines ahead of tomorrow’s banking panel testimony by Fed Chair Janet Yellen. ECONOMIC EVENTS: In the U.S., the Chicago Fed national activity index rebounded to 0.13 in January, which was nearly in-line with expectations. Existing home sales dropped 4.9% to a 4.82M rate in January, which was much worse than the expected 1.8% drop to a 4.95M unit rate. In Europe, the Ifo Institute’s measure of German business confidence rose to 106.8 in February, which was up a tenth of a percentage point from the previous month but below the 107.7 consensus forecast. Also, the Bank of Israel became the latest central bank to cut rates this year, lowering its main interest rate to 0.1% from 0.25%. COMPANY NEWS: The shares of a number of health insurers rose after the Centers for Medicare and Medicaid Services, or CMS, issued preliminary 2016 Medicare Advantage rates. According to Credit Suisse, the rates were favorable for the insurers. Following the CMS announcement made late Friday, Humana (HUM) climbed $8.40, or 5.38%, to $164.52, UnitedHealth (UNH) rose $3.78, or 3.36%, to $116.40, and WellCare (WCG) gained $4.68, or 5.53%, to $89.30. MAJOR MOVERS: Among the notable gainers was PTC Therapeutics (PTCT), which jumped $9.77, or 17.7%, to $64.96 after Reuters said the company is working with financial advisers to explore a potential sale after receiving takeover interest from several companies including Shire (SHPG) and BioMarin (BMRN). Also higher was Valeant (VRX), which rose $25.49, or 14.71%, to $198.75 after the company agreed to buy Salix (SLXP) for $158 per share and also reported better-than-forecast earnings. Salix shares, however, fell $2.09, or 1.32%, to $155.76, as a report Friday from CNBC's David Faber telegraphed the deal and suggested Valeant could value Salix around $160 per share. Among the noteworthy losers was Spectrum Pharmaceuticals (SPPI), which dropped $1.18, or 15.82%, to $6.28 after a judge ruled that a drug which could compete with the company's Fusilev treatment does not infringe on the company's intellectual property. Also lower were shares of Boeing, which fell $3.57, or 2.26%, to $154.74 after the stock was downgraded to Sell from Neutral at Goldman Sachs. INDEXES: The Dow fell 23.60, or 0.13%, to 18,116.84, the Nasdaq gained 5.01, or 0.1%, to 4,960.97, and the S&P 500 slipped 0.64, or 0.03%, to 2,109.66.
16:06 EDTMDCAMDC Partners raises quarterly dividend to 21c per share from 19c per share
MDC Partners announced that its board has declared a cash dividend of 21c per share on all of its outstanding Class A shares and Class B shares. The quarterly dividend represents a 10.5% increase from the prior dividend and will be payable on or about March 19, to shareholders of record at the close of business on March 5.
16:05 EDTMDCAMDC Partners sees FY15 revenue $1.3B-$1.33B, may not compare to consensus $1.54B
Subscribe for More Information
16:04 EDTMDCAMDC Partners reports Q4 EPS (54c), may not compare to consensus 24c
Subscribe for More Information
12:30 EDTPTCTPTC Therapeutics call active after report on exploring options
PTC Therapeutics March 60 and 70 calls are active on total call volume of 230 contracts (25 puts) on exploring sale amid interest from large peers, Reuters says. March call option implied volatility is at 99, April is at 78, June is at 67; compared to its 14-week average of 68 according to Track Data. Active call volume suggests traders taking positions for price movement.
12:29 EDTPTCTPTC Therapeutics exploring potential sale, Reuters reports
Subscribe for More Information
12:02 EDTPTCTPTC Therapeutics jumps 14% after Reuters report on exploring options
12:01 EDTPTCTPTC Therapeutics exploring sale amid interest from large peers, Reuters says
Subscribe for More Information
10:17 EDTFUELOptions with decreasing implied volatility
Subscribe for More Information
February 20, 2015
16:20 EDTFUELOn The Fly: Closing Wrap
Stocks on Wall Street opened in negative territory with time running out for Greece to reach an extension of its bailout agreement. The morning was filled with headlines from both Greek and eurozone finance leaders, many of which indicated that prospects for a deal looked grim. When reports surfaced that an agreement on an extension had been reached the Dow took off and hit its first new high of 2015. The S&P 500 followed to its own new high and the Nasdaq continued to close in on the 5,000 level. ECONOMIC EVENTS: In the U.S., Markit's flash PMI rose to 54.3 in February, versus the consensus forecast for a preliminary reading of 53.6 for the month. In Europe, the Eurogroup and Greece reached a tentative deal for an extension of the current EFSF Master Financial Assistance Facility Agreement for up to four months. The deal is predicated on Greek authorities presenting a first list of reform measures, based on the current arrangement, by the end of Monday. Also, the Eurozone flash composite PMI came in at 53.5, versus expectations for a reading of 53. The services PMI was better than expected, while the manufacturing PMI was lower than expected. COMPANY NEWS: Deere reported Q1 earnings per share of $1.12 and revenue of $6.38B, which beat consensus forecasts of 84c and $5.59B, respectively. However, Deere said company equipment sales are projected to decrease about 17% for fiscal 2015 and now sees net income to be about $1.8B, which is down from the company's prior net income outlook of $1.9B. Analysts at Wells Fargo calculate that the implied EPS guidance from Deere dropped to $5.25 from $5.50. Consensus for FY15 EPS prior to Deere's report was $5.51. Shares of the farm, construction and forestry equipment maker rose 72c, or 0.79%, to $92.43 following this morning's report. MAJOR MOVERS: Among the notable gainers was National Bank of Greece (NBG), whose shares trading in New York jumped 35c, or 21.74%, to $1.96 after the Greek aid extension deal was negotiated. Also higher was Springleaf (LEAF), which gained $4.40, or 12.88%, to $38.57 after Reuters reported that the company has beaten out rival bidders and is in advanced talks to buy consumer finance unit OneMain Financial from Citigroup (C) for more than $4B. Two stock that dropped after their earnings reports prompted multiple analyst downgrades were Noodles & Company (NDLS), which plunged $8.84, or 31.87%, to $18.90, and Rocket Fuel (FUEL), which fell $3.95, or 26.74%, to $10.82. INDEXES: The Dow rose 154.67, or 0.86%, to 18,140.44, the Nasdaq gained 31.27, or 0.63%, to 4,955.97, and the S&P 500 advanced 12.85, or 0.61%, to 2,110.30.
12:49 EDTFUELOn The Fly: Midday Wrap
Subscribe for More Information
11:12 EDTFUELRocket Fuel gets multiple downgrades after earnings, but Janney still positive
Shares of Rocket Fuel (FUEL) are plunging after the company reported lower than expected fourth quarter revenue and provided first quarter revenue guidance that came in below expectations. Several analysts responded to the news by downgrading the stock, but research firm Janney Capital wrote that the company's potential reward still outweighs its risks. Rocket Fuel has developed a decision making and modeling platform that is based on big data and artificial intelligence. WHAT'S NEW: Rocket Fuel reported a Q4 per share loss, excluding certain items, of (18c), versus analysts' consensus estimate of a (21c) per share loss. The company's revenue came in at $139.5M, versus the consensus outlook of $147M. Rocket Fuel provided Q1 revenue guidance of $57M-$58M, versus the consensus outlook of $69.5M. Of note, the company said, "Given the limited visibility inherent in our rapidly growing and changing industry, Rocket Fuel is only providing specific financial guidance for the first quarter of 2015." ANALYST REACTION: A number of firms downgraded Rocket Fuel following the company's results. Piper Jaffray analyst Gene Munster downgraded the shares to Neutral from Overweight, saying that the company's transition to "more of a software platform" has made its risk/reward ratio unattractive, while its results raise questions about its business model. Meanwhile, Oppenheimer analyst Jason Helfstein downgraded the shares to Perform from Outperform, as he believes that the company lacks positive catalysts. Needham also downgraded the shares, cutting its rating on the stock to Hold from Buy. Although Rocket Fuel provided "very disappointing" Q1 guidance and the company is running into difficulties selling its products at trading desks, the company can overcome its challenges over time, Janney Capital analyst Murali Sankar contended. Rocket Fuel has started to build stronger relationships with the executives of trading firms, according to the analyst, who lowered his fair value estimate on the shares to $17.50 from $25.50, but kept a Buy rating on the stock. PRICE ACTION: In late morning trading, Rocket Fuel fell 25% to $11. Over the last year the stock is down about 79%.
10:01 EDTFUELOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:15 EDTFUELRocket Fuel downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
08:57 EDTFUELRocket Fuel potenial reward still outweighs risks, says Janney Capital
Subscribe for More Information
08:21 EDTFUELRocket Fuel downgraded on lack of catalysts
Subscribe for More Information
08:04 EDTFUELRocket Fuel downgraded to Hold from Buy at Needham
Subscribe for More Information
06:01 EDTFUELRocket Fuel downgraded to Perform from Outperform at Oppenheimer
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use